Skip to main content
. Author manuscript; available in PMC: 2010 Feb 22.
Published in final edited form as: Biochem J. 2009 Apr 1;419(1):51–56. doi: 10.1042/BJ20081359

Figure 2. Cisplatin protects MBR2 from tryptic digestion at Lys164.

Figure 2

MALDI–TOF mass spectra of trypsinolysis products of the untreated MBR1–4 (A), the protein treated with cisplatin (B) and Cu(I) (C). Peaks corresponding to the peptides Leu147–Lys164 and Leu147–Lys167 are shown by arrows. Cysteine residues in the copper-binding motif are underlined.